Loading clinical trials...
Loading clinical trials...
Short-term Effects of Dapagliflozin on Fasting and Postprandial Glucose Homeostasis in Male Type 1 Diabetes Patients.
Conditions
Interventions
Dapagliflozin
Locations
1
Austria
Medical University Innsbruck, Department of Internal Medicine I
Innsbruck, Tyrol, Austria
Start Date
August 1, 2014
Primary Completion Date
July 29, 2016
Completion Date
February 8, 2017
Last Updated
March 16, 2023
NCT06817252
NCT07175701
NCT07043816
NCT06803836
NCT04821752
NCT04994327
Lead Sponsor
Medical University Innsbruck
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions